Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Takeda and Zinfandel write off yet another Alzheimer’s PhIII after Actos fails a key interim test
Takeda and Zinfandel write off yet another Alzheimer’s PhIII after Actos fails a key interim test
Takeda and Zinfandel write off yet another Alzheimer’s PhIII after Actos fails a key interim test
Submitted by
admin
on January 25, 2018 - 9:37am
Source:
Endpoints
News Tags:
Takeda
Zinfandel Pharmaceuticals
Actos
Alzheimer's disease
Headline:
Takeda and Zinfandel write off yet another Alzheimer’s PhIII after Actos fails a key interim test
Do Not Allow Advertisers to Use My Personal information
